Erythropoietin (EPO) receptor

Pipeline Summary for Products Targeting Erythropoietin (EPO) receptor
Print this Phases of Development Preclinical Phase I Phase II Phase III Registration Approved Marketed Cancer 0 0 0 1 0 0 0 Cardiovascular 0 0 1 0 0 0 0 Hematology 3 2 0 1 1 2 12 Neurology 0 1 1 0 0 0 0 Copyright ©2013 BioCentury Publications, Inc. All Rights Reserved